Methadone Patient Access to Collaborative Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Arizona
About this trial
The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose.
It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Staff providing methadone treatment services at the enrolled opioid treatment programs
Disqualifiers
Patients receiving methadone treatment at the enrolled opioid treatment programs
Trial design
Design model
Parallel
Treatments tested in this trial
MPACT
Other interventionFour components are part of this intervention: 1) accredited training about patient centered, trauma-informed care and the standard of care under the current federal regulation (42CFRpart8), 2) education about trauma and trauma symptoms including vicarious (work related) trauma and navigation to symptoms screening and resources including treatment, 3) reflective supervision for counseling, case management and peer staff, and 4) clinic self assessment for trauma-informed and patient centered care
Treatment groups
1,080 Participants
are divided into 2 treatment groupsGroup A: MPACT InterventionExperimental treatment 1 intervention
Group B: Control for MPACTNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Days in Treatment to treatment interruption
Time (days) to treatment interruption
Time frame
18 months2
Missed doses
Missed methadone doses in the last 30 days
Time frame
20 months3
In Treatment- Point in time
Point in time in treatment (0 day, 30 day, 60, day, 90 day)
Time frame
18 months4
Number of patients reporting opioid overdoses while in methadone treatment
Reported overdoses by patients in methadone treatment during the trial period by survey measured at 5 points during the study period.
Time frame
18 monthsSecondary outcomes
1
Number of staff experiencing vicarious (work related) stress
Post traumatic stress symptoms and vicarious (work related) trauma symptoms measured by the Vicarious Trauma Scale (VTS). Total scores can be grouped into three categories to represent low (8-28), moderate (29-42) and high (43-56) levels of vicarious trauma symptoms
Time frame
18 months2
Number of patients and staff experiencing post traumatic stress symptoms
Post traumatic stress symptoms measured by the 8-item PCL-5 measuring post traumatic stress symptoms. Scores range from 0-80, with higher scores representing greater levels of traumatic stress symptomatology.
Time frame
18 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov